«A systematic review of modafinil: Potential clinical uses and mechanisms of action». The Journal of Clinical Psychiatry67 (4): 554–66. April 2006. doi:10.4088/jcp.v67n0406. PMID16669720.
«Absence of mood switch with and tolerance to modafinil: a replication study from a large private practice». Journal of Affective Disorders95 (1–3): 111–4. October 2006. doi:10.1016/j.jad.2006.01.010. PMID16737742.
«Long-term efficacy and safety of modafinil (PROVIGIL((R))) for the treatment of excessive daytime sleepiness associated with narcolepsy». Sleep Medicine1 (3): 231–243. July 2000. doi:10.1016/s1389-9457(00)00031-9. PMID10828434.
«Involvement of central histaminergic systems in modafinil-induced but not methylphenidate-induced increases in locomotor activity in rats». European Journal of Pharmacology578 (2–3): 209–15. January 2008. doi:10.1016/j.ejphar.2007.09.009. PMID17920581.
«Modafinil evokes striatal [(3)H]dopamine release and alters the subjective properties of stimulants». European Journal of Pharmacology568 (1–3): 112–23. July 2007. doi:10.1016/j.ejphar.2007.03.044. PMID17477916.
«Modafinil enhances extracellular levels of dopamine in the nucleus accumbens and increases wakefulness in rats». Behavioural Brain Research176 (2): 353–7. January 2007. doi:10.1016/j.bbr.2006.10.016. PMID17098298.
«Variations in extracellular monoamines in the prefrontal cortex and medial hypothalamus after modafinil administration: a microdialysis study in rats». NeuroReport12 (16): 3533–7. November 2001. doi:10.1097/00001756-200111160-00032. PMID11733706.
«Differential enhancement of dialysate serotonin levels in distinct brain regions of the awake rat by modafinil: possible relevance for wakefulness and depression». Journal of Neuroscience Research68 (1): 107–12. April 2002. doi:10.1002/jnr.10196. PMID11933055.
«Electrophysiological and amperometric evidence that modafinil blocks the dopamine uptake transporter to induce behavioral activation». Neuroscience252: 118–24. November 2013. doi:10.1016/j.neuroscience.2013.07.071. PMID23933217.
«In vivo activity of modafinil on dopamine transporter measured with positron emission tomography and [¹⁸F]FE-PE2I». The International Journal of Neuropsychopharmacology17 (5): 697–703. May 2014. doi:10.1017/S1461145713001612. PMID24451483.
«Dopaminergic mediation of the discriminative stimulus functions of modafinil in rats». Psychopharmacology232 (24): 4411–9. December 2015. doi:10.1007/s00213-015-4065-0. PMID26374456.
«Non-amphetaminic mechanism of stimulant locomotor effect of modafinil in mice». European Neuropsychopharmacology5 (4): 509–14. December 1995. doi:10.1016/0924-977x(95)00041-m. PMID8998404.
«Wake promoting agents: search for next generation modafinil, lessons learned: part III». Bioorganic & Medicinal Chemistry Letters22 (11): 3751–3. June 2012. doi:10.1016/j.bmcl.2012.04.031. PMID22546675.
«Anti-narcoleptic agent modafinil and its sulfone: a novel facile synthesis and potential anti-epileptic activity». Neurochemical Research29 (8): 1481–6. August 2004. doi:10.1023/b:nere.0000029559.20581.1a. PMID15260124.
«Dopamine D2High receptors stimulated by phencyclidines, lysergic acid diethylamide, salvinorin A, and modafinil». Synapse63 (8): 698–704. August 2009. doi:10.1002/syn.20647. PMID19391150.
«Provigil Prescribing Information»(PDF). United States Food and Drug Administration. Teva Pharmaceuticals USA, Inc. Ιανουαρίου 2015. Ανακτήθηκε στις 18 Ιουλίου 2015.
«Provigil: Prescribing information»(PDF). United States Food and Drug Administration. Cephalon, Inc. Ιανουαρίου 2015. Ανακτήθηκε στις 16 Αυγούστου 2015.
«In vitro inhibition and induction of human hepatic cytochrome P450 enzymes by modafinil». Drug Metabolism and Disposition28 (6): 664–71. June 2000. PMID10820139.
«A systematic review of modafinil: Potential clinical uses and mechanisms of action». The Journal of Clinical Psychiatry67 (4): 554–66. April 2006. doi:10.4088/jcp.v67n0406. PMID16669720.
«Absence of mood switch with and tolerance to modafinil: a replication study from a large private practice». Journal of Affective Disorders95 (1–3): 111–4. October 2006. doi:10.1016/j.jad.2006.01.010. PMID16737742.
«Long-term efficacy and safety of modafinil (PROVIGIL((R))) for the treatment of excessive daytime sleepiness associated with narcolepsy». Sleep Medicine1 (3): 231–243. July 2000. doi:10.1016/s1389-9457(00)00031-9. PMID10828434.
«Involvement of central histaminergic systems in modafinil-induced but not methylphenidate-induced increases in locomotor activity in rats». European Journal of Pharmacology578 (2–3): 209–15. January 2008. doi:10.1016/j.ejphar.2007.09.009. PMID17920581.
«Modafinil evokes striatal [(3)H]dopamine release and alters the subjective properties of stimulants». European Journal of Pharmacology568 (1–3): 112–23. July 2007. doi:10.1016/j.ejphar.2007.03.044. PMID17477916.
«Modafinil enhances extracellular levels of dopamine in the nucleus accumbens and increases wakefulness in rats». Behavioural Brain Research176 (2): 353–7. January 2007. doi:10.1016/j.bbr.2006.10.016. PMID17098298.
«Variations in extracellular monoamines in the prefrontal cortex and medial hypothalamus after modafinil administration: a microdialysis study in rats». NeuroReport12 (16): 3533–7. November 2001. doi:10.1097/00001756-200111160-00032. PMID11733706.
«Effect of the wake-promoting agent modafinil on sleep-promoting neurons from the ventrolateral preoptic nucleus: an in vitro pharmacologic study». Sleep27 (1): 19–25. February 2004. PMID14998233.
«Differential enhancement of dialysate serotonin levels in distinct brain regions of the awake rat by modafinil: possible relevance for wakefulness and depression». Journal of Neuroscience Research68 (1): 107–12. April 2002. doi:10.1002/jnr.10196. PMID11933055.
«Electrophysiological and amperometric evidence that modafinil blocks the dopamine uptake transporter to induce behavioral activation». Neuroscience252: 118–24. November 2013. doi:10.1016/j.neuroscience.2013.07.071. PMID23933217.
«In vivo activity of modafinil on dopamine transporter measured with positron emission tomography and [¹⁸F]FE-PE2I». The International Journal of Neuropsychopharmacology17 (5): 697–703. May 2014. doi:10.1017/S1461145713001612. PMID24451483.
«Dopaminergic mediation of the discriminative stimulus functions of modafinil in rats». Psychopharmacology232 (24): 4411–9. December 2015. doi:10.1007/s00213-015-4065-0. PMID26374456.
«Non-amphetaminic mechanism of stimulant locomotor effect of modafinil in mice». European Neuropsychopharmacology5 (4): 509–14. December 1995. doi:10.1016/0924-977x(95)00041-m. PMID8998404.
«Wake promoting agents: search for next generation modafinil, lessons learned: part III». Bioorganic & Medicinal Chemistry Letters22 (11): 3751–3. June 2012. doi:10.1016/j.bmcl.2012.04.031. PMID22546675.
«Anti-narcoleptic agent modafinil and its sulfone: a novel facile synthesis and potential anti-epileptic activity». Neurochemical Research29 (8): 1481–6. August 2004. doi:10.1023/b:nere.0000029559.20581.1a. PMID15260124.
«Dopamine D2High receptors stimulated by phencyclidines, lysergic acid diethylamide, salvinorin A, and modafinil». Synapse63 (8): 698–704. August 2009. doi:10.1002/syn.20647. PMID19391150.
«医疗用医薬品の添付文书情报-モディオダール锭100mg». 独立行政法人 医薬品医疗机器総合机构 (στα Japanese). Αρχειοθετήθηκε από το πρωτότυπο στις 9 Φεβρουαρίου 2019. Ανακτήθηκε στις 9 Φεβρουαρίου 2019.CS1 maint: Μη αναγνωρίσιμη γλώσσα (link)
punemirror.in
«Pilot pill project». News – City. PuneMirror. 16 Φεβρουαρίου 2011. Αρχειοθετήθηκε από το πρωτότυπο στις 19 Μαρτίου 2012. Ανακτήθηκε στις 4 Ιουλίου 2012.
«Pilot pill project». News – City. PuneMirror. 16 Φεβρουαρίου 2011. Αρχειοθετήθηκε από το πρωτότυπο στις 19 Μαρτίου 2012. Ανακτήθηκε στις 4 Ιουλίου 2012.
«医疗用医薬品の添付文书情报-モディオダール锭100mg». 独立行政法人 医薬品医疗机器総合机构 (στα Japanese). Αρχειοθετήθηκε από το πρωτότυπο στις 9 Φεβρουαρίου 2019. Ανακτήθηκε στις 9 Φεβρουαρίου 2019.CS1 maint: Μη αναγνωρίσιμη γλώσσα (link)